Michael S Hwang

2PUBLICATIONS
52CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancer.

Alexander H Pearlman, Brian J Mog, Michael S Hwang

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

Pageof 1